Literature DB >> 33741433

Expression of the tumor-expressed protein MageB2 enhances rRNA transcription.

María Fátima Ladelfa1, Leticia Yamila Peche2, Gastón Ezequiel Amato1, Micaela Carolina Escalada1, Stefania Zampieri3, Franco Andrés Pascucci1, Andres Fernandez Benevento4, Dario Fernandez Do Porto4, Andrea Dardis3, Claudio Schneider5, Martin Monte6.   

Abstract

An essential requirement for cells to sustain a high proliferating rate is to be paired with enhanced protein synthesis through the production of ribosomes. For this reason, part of the growth-factor signaling pathways, are devoted to activate ribosome biogenesis. Enhanced production of ribosomes is a hallmark in cancer cells, which is boosted by different mechanisms. Here we report that the nucleolar tumor-protein MageB2, whose expression is associated with cell proliferation, also participates in ribosome biogenesis. Studies carried out in both siRNA-mediated MageB2 silenced cells and CRISPR/CAS9-mediated MageB2 knockout (KO) cells showed that its expression is linked to rRNA transcription increase independently of the cell proliferation status. Mechanistically, MageB2 interacts with phospho-UBF, a protein which causes the recruitment of RNA Pol I pre-initiation complex required for rRNA transcription. In addition, cells expressing MageB2 displays enhanced phospho-UBF occupancy at the rDNA gene promoter. Proteomic studies performed in MageB2 KO cells revealed impairment in ribosomal protein (RPs) content. Functionally, enhancement in rRNA production in MageB2 expressing cells, was directly associated with an increased dynamic in protein synthesis. Altogether our results unveil a novel function for a tumor-expressed protein from the MAGE-I family. Findings reported here suggest that nucleolar MageB2 might play a role in enhancing ribosome biogenesis as part of its repertoire to support cancer cell proliferation.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRISPR/CAS9; Cancer; MAGE; Protein synthesis; Proteomics; Ribosome biogenesis; rRNA transcription

Year:  2021        PMID: 33741433     DOI: 10.1016/j.bbamcr.2021.119015

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  1 in total

1.  ZNF276 promotes the malignant phenotype of breast carcinoma by activating the CYP1B1-mediated Wnt/β-catenin pathway.

Authors:  Ting Lei; Wenwu Zhang; Yongyin He; Shi Wei; Xiaoyu Song; Yi Zhu; Guoqing Luo; Zhenzhan Kuang; Guanjie Li; Quan Zhou; Zhaohui Sun; Bin Xiao; Linhai Li
Journal:  Cell Death Dis       Date:  2022-09-10       Impact factor: 9.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.